Dr Martin Putera

​Dr Martin Putera received his medical degree from Duke-NUS Graduate Medical School, Singapore. He completed his training in SingHealth Internal Medicine residency and obtained Membership of Royal College of Physician of the United Kingdom (MRCP, UK) and Master of Medicine (MMed). He then completed training in SingHealth Gastroenterology Senior Residency and obtained Singapore Accreditation Board (SAB) certification as specialist in Gastroenterology and Hepatology.

• ​Doctor of Medicine (MD), Duke-NUS Graduate Medical School, Singapore
• Master of Medicine (Int Med), National University of Singapore
• Membership of the Royal College of Physicians of the United Kingdom
• Singapore Accreditation Board in Gastroenterology

• ​Member, Royal College of Physician (UK)
• Member, American Society of Gastrointestinal Endoscopy
• Member, American College of Gastroenterology
  

​SingHealth RiSE Outstanding Resident award (2022)

• ​Wong YJ, Li J, Liu C, Chen Z, Chan YH, Putera M, Teh KB, Ang TL, Zhao L, Yan Z, Kumar R, Li X, Qi X. CHESS-ALARM score to stratify decompensation risk in compensated advanced chronic liver disease patients: An international multicenter study. J Gastroenterol Hepatol. 2022 Jun;37(6):1043-1051.
• Putera M, Teh KB, Kumar R, Wong YJ. Small esophageal varices in compensated cirrhosis patients: to treat or not to treat? J Hepatol. 2021 Aug;75(2):491-492.
• Wong YJ, Kew GS, Tan PS, Chen Z, Putera M, Yip WA, Ang TL, Fock KM, Lee GH, Hsiang J, Huang DQ, Kwek A, Muthiah MD, Kumar R, Tan M, Tan J, Thurairajah PH, Teo EK, Tai BC, Lim SG. Novel albumin, bilirubin and platelet criteria for the exclusion of high-risk varices in compensated advanced chronic liver disease: A validation study. Clin Res Hepatol Gastroenterol. 2021 Nov;45(6):101598.
• Putera M, Tan CK, Wong YJ, Kumar R. Higher mortality in acute variceal haemorrhage: Is fresh frozen plasma alone to be blamed? Liver Int. 2021 Aug;41(8):1977-1978.
• Putera M, Roark R, Lopes RD, Udayakumar K, Peterson ED, Califf RM, Shah BR.Translation of acute coronary syndrome therapies: from evidence to routine clinical practice. Am Heart J. 2015 Feb;169(2):266-73.